Merck resolves previously disclosed seven-year investigation
22 November 2011 | By Merck
Merck has reached a resolution with federal and state authorities regarding a previously disclosed investigation concerning Vioxx...
List view / Grid view
22 November 2011 | By Merck
Merck has reached a resolution with federal and state authorities regarding a previously disclosed investigation concerning Vioxx...
21 November 2011 | By Pfizer
10-year lease marks a strategic partnership between the academic research community and industry to boost innovation...
21 November 2011 | By Gilead Sciences
Gilead Sciences, Inc., will acquire Pharmasset, Inc., for $137 per share in cash...
21 November 2011 | By Abbott
Abbott received approval from the U.S. FDA for a new Chagas in vitro diagnostic test...
21 November 2011 | By Pfizer
Pfizer Inc. announced that its Market Authorisation Application for tofacitinib...
18 November 2011 | By Roche
FDA Commissioner revokes approval of Avastin for treatment of mBC in the US...
18 November 2011 | By AstraZeneca
CAPRELSA receives a positive opinion...
17 November 2011 | By GlaxoSmithKline
GSK welcomes the EC’s commitment...
17 November 2011 | By GlaxoSmithKline
GSK welcomed the decision of the GAVI...
17 November 2011 | By Eli Lilly and Company
Eli Lilly and Company is providing more than $4 million in additional funding...
17 November 2011 | By kdm communications limited
The fourth annual Tecan Symposium, welcomed leading genomics, proteomics & biobanking experts from around the globe...
17 November 2011 | By Novartis
Discovery of a new class of dual-acting antimalarial compounds...
16 November 2011 | By GlaxoSmithKline
GlaxoSmithKline announced that topline results have been received...
16 November 2011 | By kdm communications limited
Syrris, is pleased to be a sponsor of the 1st Flow Chemistry Symposium (1st FCS)...
16 November 2011 | By Eli Lilly and Company
An analysis of the TRITON-TIMI 38 trial presented...